Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: JF Quinnelly who wrote (1090)	7/23/1999 10:43:00 PM
From: LLCF	Respond to of 3202

Thanks for the informative post... DAK

To: JF Quinnelly who wrote (1090)	7/24/1999 12:35:00 AM
From: Biomaven	Read Replies (2) \| Respond to of 3202

Industrial testing, such as at a meat packing facility testing for e-coli, could be a very profitable business and the AFFX chip might not be the platform of choice. IGEN is the obvious leader in this area. Their immediate future is clouded by their present squabble with Roche, but I think they are likely a long term winner in testing of all sorts. (And high-throughput screening in particular). It's a razor/razorblade business (with reagents being the razorblades), which makes it a bit tricky to analyze in the early stages. Peter